Quantum BioPharma Financials - Benzinga

Quantum BioPharma Ltd

QNTMNASDAQ

Trade with Public

Trade with Public

$3.24

0.299.83%

At close: Sep 4, 5:00 PM EST

$3.30

0.061.85%

After Hours: Sep 4, 7:08 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Compare Stock Report

Quantum BioPharma Financials

Quantum BioPharma (QNTM) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Quantum BioPharma Q4 EPS $(0.71) Beats $(0.93) Estimate

Quantum BioPharma (NASDAQ:QNTM) reported quarterly losses of $(0.71) per share which beat the analyst consensus estimate of $(0.93) by 23.66 percent. This is a 65.53 percent increase over losses of $(2.06) per share from

Benzinga Newsdesk

PRO
Quantum BioPharma Q3 EPS $(1.25) Misses $(0.08) Estimate

Quantum BioPharma (NASDAQ:QNTM) reported quarterly losses of $(1.25) per share which missed the analyst consensus estimate of $(0.08) by 1462.5 percent. This is a 71.4 percent increase over losses of $(4.37) per share

Benzinga Newsdesk

PRO
Quantum BioPharma Q2 EPS $(3.23) Compared With $(0.08) YoY

Quantum BioPharma (NASDAQ:QNTM) reported quarterly losses of $(3.23) per share which missed the analyst consensus estimate of $(0.07) by 4514.29 percent. This is a 3937.5 percent decrease over losses of $(0.08) per share

Benzinga Newsdesk

Earnings Scheduled For May 6, 2025

Benzinga Insights

Dow Edges Higher; US Weekly Jobless Claims Increase

Avi Kapoor

Gold Moves Higher; Estée Lauder Shares Slide

Avi Kapoor